Your browser doesn't support javascript.
loading
Pharmacokinetics/pharmacodynamics, safety, and tolerability of fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting in pediatric cancer patients.
Mora, Jaume; Valero, Miguel; DiCristina, Cara; Jin, Mandy; Chain, Anne; Bickham, Kara.
  • Mora J; Department of Pediatric Oncology, Hospital Sant Joan de Déu, Barcelona, Spain.
  • Valero M; Department of Pediatrics, Unit of Hematology and Oncology, Hospital Carlos Van Buren de Valparaíso, Valparaíso, Chile.
  • DiCristina C; Merck & Co., Inc., Kenilworth, New Jersey.
  • Jin M; Merck & Co., Inc., Kenilworth, New Jersey.
  • Chain A; Merck & Co., Inc., Kenilworth, New Jersey.
  • Bickham K; Merck & Co., Inc., Kenilworth, New Jersey.
Pediatr Blood Cancer ; 66(6): e27690, 2019 06.
Article en En | MEDLINE | ID: mdl-30900392
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vómitos / Protocolos de Quimioterapia Combinada Antineoplásica / Morfolinas / Náusea / Neoplasias Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male / Newborn Idioma: En Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vómitos / Protocolos de Quimioterapia Combinada Antineoplásica / Morfolinas / Náusea / Neoplasias Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male / Newborn Idioma: En Año: 2019 Tipo del documento: Article